Gurdeep Singh1*, Sarthak Parikh2 and Ujval Choksi3
1Internal Medicine/Endocrinology, Our Lady of Lourdes Memorial Hospital, Binghamton, NY, USA
2Nova Southeastern University College of Osteopathic Medicine, Monroe, NJ, USA
3Our Lady of Lourdes Memorial Hospital, Binghamton, NY, USA
*Corresponding Author: Gurdeep Singh, Internal Medicine/Endocrinology, Our Lady of Lourdes Memorial Hospital, Binghamton, NY, USA.
Received: March 15, 2022; Published: April 29, 2022
Telogen effluvium (TE) is a reversible form of hair loss which is an identified sequela of COVID-19 infection. Generally diagnosed by a hair-pull test or a modified wash test, it can cause a non-scarring shedding of hair for months after the resolution of COVID-19. The pathophysiology of TE secondary to COVID-19 is still being understood. Here, we describe a 45-year-old unvaccinated female who was diagnosed with a severe case of telogen effluvium approximately 3 months after her COVID-19 diagnosis, with hair loss that exceeded 80% of her total hair.
Keywords: Telogen Effluvium; COVID 19; Hair Loss
Citation: Gurdeep Singh., et al. “A Case of Telogen Effluvium as COVID Sequelae". Acta Scientific Women's Health 4.5 (2022): 66-69.
Copyright: © 2022 Gurdeep Singh., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.